NO305957B1 - Farmakologisk aktive enantiomerer - Google Patents

Farmakologisk aktive enantiomerer

Info

Publication number
NO305957B1
NO305957B1 NO955345A NO955345A NO305957B1 NO 305957 B1 NO305957 B1 NO 305957B1 NO 955345 A NO955345 A NO 955345A NO 955345 A NO955345 A NO 955345A NO 305957 B1 NO305957 B1 NO 305957B1
Authority
NO
Norway
Prior art keywords
pharmacologically active
active enantiomers
enantiomers
alk
enantiomer
Prior art date
Application number
NO955345A
Other languages
English (en)
Norwegian (no)
Other versions
NO955345D0 (no
NO955345L (no
Inventor
Leandro Baiocchi
Valerio Cioli
Original Assignee
Angelini Francesco Ist Ricerca
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Francesco Ist Ricerca filed Critical Angelini Francesco Ist Ricerca
Publication of NO955345D0 publication Critical patent/NO955345D0/no
Publication of NO955345L publication Critical patent/NO955345L/no
Publication of NO305957B1 publication Critical patent/NO305957B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
NO955345A 1993-07-01 1995-12-29 Farmakologisk aktive enantiomerer NO305957B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT93MI001418A IT1268414B1 (it) 1993-07-01 1993-07-01 Enantiomeri farmacologicamente attivi
PCT/EP1994/002061 WO1995001354A1 (en) 1993-07-01 1994-06-21 Pharmacologically active enantiomers

Publications (3)

Publication Number Publication Date
NO955345D0 NO955345D0 (no) 1995-12-29
NO955345L NO955345L (no) 1996-02-29
NO305957B1 true NO305957B1 (no) 1999-08-23

Family

ID=11366510

Family Applications (1)

Application Number Title Priority Date Filing Date
NO955345A NO305957B1 (no) 1993-07-01 1995-12-29 Farmakologisk aktive enantiomerer

Country Status (30)

Country Link
US (3) US5741907A (xx)
EP (1) EP0707587B1 (xx)
JP (1) JP3096065B2 (xx)
KR (1) KR100306018B1 (xx)
CN (3) CN1046281C (xx)
AT (1) ATE158796T1 (xx)
AU (1) AU689478B2 (xx)
BG (1) BG61815B1 (xx)
BR (1) BR9406996A (xx)
CA (1) CA2166470C (xx)
CZ (1) CZ289526B6 (xx)
DE (1) DE69405999T2 (xx)
DK (1) DK0707587T3 (xx)
ES (1) ES2111309T3 (xx)
FI (1) FI111943B (xx)
GE (1) GEP19991791B (xx)
GR (1) GR3025806T3 (xx)
HK (2) HK1018781A1 (xx)
HU (1) HU221631B1 (xx)
IT (1) IT1268414B1 (xx)
LV (1) LV11546B (xx)
NO (1) NO305957B1 (xx)
NZ (1) NZ268014A (xx)
PL (1) PL181831B1 (xx)
RO (2) RO116899B1 (xx)
RU (1) RU2128180C1 (xx)
SK (1) SK281060B6 (xx)
UA (1) UA53607C2 (xx)
WO (1) WO1995001354A1 (xx)
ZA (1) ZA944570B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1268414B1 (it) * 1993-07-01 1997-02-27 Angelini Francesco Ist Ricerca Enantiomeri farmacologicamente attivi
JP2009018992A (ja) * 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
RU2706700C1 (ru) 2019-09-24 2019-11-20 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3365453A (en) * 1963-10-28 1968-01-23 Sterling Drug Inc 1-phenyl-4-lower-alkyl-2-piperazinones
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
US5303837A (en) * 1991-03-05 1994-04-19 Portola Packaging, Inc. One-piece fitment and plug with tamper-evident band
US5543563A (en) * 1992-01-17 1996-08-06 Istituto Ricerca Francesco Angelini S.P.A. Alkyl derivatives of trazodone with CNS activity
IT1258790B (it) * 1992-01-17 1996-02-29 Angelini Francesco Ist Ricerca Alchil derivati del trazodone
IT1268414B1 (it) * 1993-07-01 1997-02-27 Angelini Francesco Ist Ricerca Enantiomeri farmacologicamente attivi
US5399765A (en) * 1994-05-23 1995-03-21 Sepracor, Inc. Enantioselective preparation of optically pure albuterol

Also Published As

Publication number Publication date
FI956334A (fi) 1996-02-19
FI956334A0 (fi) 1995-12-29
WO1995001354A1 (en) 1995-01-12
ITMI931418A1 (it) 1995-01-01
KR100306018B1 (ko) 2001-11-30
LV11546A (lv) 1996-10-20
US5973150A (en) 1999-10-26
HU221631B1 (hu) 2002-12-28
AU7072994A (en) 1995-01-24
HK1018777A1 (en) 2000-01-07
HK1018781A1 (en) 2000-01-07
PL181831B1 (pl) 2001-09-28
EP0707587A1 (en) 1996-04-24
PL312419A1 (en) 1996-04-15
ES2111309T3 (es) 1998-03-01
ITMI931418A0 (it) 1993-07-01
JPH08512036A (ja) 1996-12-17
DE69405999D1 (de) 1997-11-06
BR9406996A (pt) 1996-09-10
RU2128180C1 (ru) 1999-03-27
CA2166470C (en) 2001-12-18
CN1136201C (zh) 2004-01-28
BG61815B1 (bg) 1998-06-30
CN1136200C (zh) 2004-01-28
CN1215053A (zh) 1999-04-28
JP3096065B2 (ja) 2000-10-10
ATE158796T1 (de) 1997-10-15
LV11546B (en) 1997-02-20
AU689478B2 (en) 1998-04-02
CN1129939A (zh) 1996-08-28
DK0707587T3 (da) 1998-05-11
CZ289526B6 (cs) 2002-02-13
UA53607C2 (uk) 2003-02-17
ZA944570B (en) 1995-04-11
NO955345D0 (no) 1995-12-29
NZ268014A (en) 1997-08-22
HU9503876D0 (en) 1996-02-28
FI111943B (fi) 2003-10-15
GEP19991791B (en) 1999-10-05
DE69405999T2 (de) 1998-04-16
US5817815A (en) 1998-10-06
EP0707587B1 (en) 1997-10-01
US5741907A (en) 1998-04-21
NO955345L (no) 1996-02-29
CA2166470A1 (en) 1995-01-12
CZ348595A3 (en) 1996-04-17
BG100331A (bg) 1996-09-30
SK281060B6 (sk) 2000-11-07
RO116899B1 (ro) 2001-07-30
SK166495A3 (en) 1996-09-04
HUT73230A (en) 1996-07-29
RO121031B1 (ro) 2006-11-30
GR3025806T3 (en) 1998-03-31
IT1268414B1 (it) 1997-02-27
CN1215052A (zh) 1999-04-28
CN1046281C (zh) 1999-11-10

Similar Documents

Publication Publication Date Title
EA199800141A1 (ru) Гетероциклические соединения
KR880000400A (ko) 융합된 사이클릭 아제핀-2-온 유도체 및 그의 제조방법
ES8802420A1 (es) Un procedimiento para la preparacion de un derivado de acido 5-imidazolcarboxilico
EP0154234A3 (en) Substituted tyrosil alanine dipeptide amides
IT1268414B1 (it) Enantiomeri farmacologicamente attivi
AU586477B2 (en) Hexenoic acids
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
ATE151987T1 (de) Verwendung von 3-pyridazinone zur verringerung der blutplätchenzahl
ES8602789A1 (es) Procedimiento para preparar derivados de 14-hidroxiimino- eburnano racemicos y opticamente activos
KR890009886A (ko) 심기능 부전의 예방 및 치료제
AU2013888A (en) Uricosuric composition
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ES8703421A1 (es) Procedimiento para preparar derivados de pirrolidindiona.
EP0310969A3 (en) Pyrido-benzothiazine derivatives having high antibacterial activity and high bioavailability to tissues